SCHEMBL8060495

SCHEMBL8060495

O=C(Nc1cccc2c(S(=O)(=O)[O-])cccc12)OCc1ccccc1.[Na+]

nearest known ligand 0.53

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TYMS known ✓ P04818 2/20 0.49
CA12 known ✓ O43570 2/20 0.45
CA1 known ✓ P00915 2/20 0.45
CA2 known ✓ P00918 2/20 0.45
NPC1 O15118 1/20 0.53
RAB9A P51151 1/20 0.53
PLAU P00749 1/20 0.53
CASP3 P42574 1/20 0.50
PTPN1 P18031 1/20 0.47
MGLL Q99685 1/20 0.45
CA9 Q16790 2/20 0.45
KMT2A Q03164 1/20 0.44
POLB P06746 1/20 0.44
ALDH1A1 P00352 1/20 0.44
HPGD P15428 1/20 0.44
MAOB P27338 1/20 0.43
TRPV1 Q8NER1 4/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8395502 0.88 NPC1 (0.56) NPC1RAB9APLAUCASP3TYMS
SCHEMBL29892522 0.88 NPC1 (0.56) NPC1RAB9APLAUCASP3TYMS
SCHEMBL29892518 0.88 NPC1 (0.56) NPC1RAB9APLAUCASP3TYMS
SCHEMBL8042550 0.86 NPC1 (0.54) NPC1RAB9APLAUCASP3TYMS
SCHEMBL9125523 0.75 NPC1 (0.58) NPC1RAB9APLAUCASP3MGLL
SCHEMBL21878720 0.74 EDNRA (0.52) KMT2AALDH1A1HPGD
SCHEMBL27786325 0.74 NPC1 (0.57) NPC1RAB9APLAUCASP3PTPN1
SCHEMBL9093600 0.73 PLAU (0.55) NPC1RAB9APLAUCASP3PTPN1
SCHEMBL3786444 0.73 NPC1 (0.68) NPC1RAB9APLAUCASP3PTPN1
SCHEMBL14183610 0.72 SMN1; SMN2 (0.66) NPC1RAB9APLAUKMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6083951-A FOR THE TREATMENT OF DISEASES OR MEDICAL CONDITIONS SUCH AS HYPERTENSION, PULMONARY HYPERTENSION, CARDIAC OR CEREBRAL CIRCULATORY DISEASE AND RENAL DISEASE ZENECA LIMITED (GB) 2000-07-04 US disclosed
US-5861401-A TREATMENT OF CONGESTIVE HEART FAILURE ZENECA LIMITED (GB) 1999-01-19 US disclosed
EP-0752986-A1 N-HETEROCYCLYL SULPHONAMIDE DERIVATIVES AND THEIR USE AS ENDOTHELIN ANTAGONISTS ZENECA LIMITED (GB) 1997-01-15 EP disclosed
WO-1995026957-A1 N-HETEROCYCLYL SULPHONAMIDE DERIVATIVES AND THEIR USE AS ENDOTHELIN ANTAGONISTS ZENECA LIMITED (GB) 1995-10-12 WO disclosed